Peptide

Offering you a complete choice of products which include tirzepatide 40mg peptide, tirzepatide 60 peptide, tirzepatide 20mg peptide and tirzepatide 10mg peptide.

Tirzepatide 40mg peptide

Request Callback

₹ 9395 / Vial Get Latest Price

Product Brochure
Strength40mg
Packaging Size0.5 ml
Packaging TypeInjection
Brandziska
Manufacturerziska
PrescriptionNo
Usage / Application2 types of diabetes
Storage Conditionsnormal temperature
made inIndia
shelf life36 month

Minimum order quantity: 4 Vial

Tirzepatide 40mg – Advanced Support for Diabetes and Weight Management

Tirzepatide 40mg is a cutting-edge injectable medication designed to help manage type 2 diabetes and support weight loss. It works by activating both GIP and GLP-1 receptors, two natural hormone pathways that regulate blood sugar levels and appetite. This dual-action approach makes Tirzepatide more effective than many traditional treatments in improving glycemic control and promoting sustained weight reduction.

This medication is typically used once a week and may be part of a long-term treatment plan for individuals who have not achieved adequate results with other therapies. Tirzepatide helps lower blood sugar by increasing insulin release when needed and reducing the amount of glucose produced by the liver. At the same time, it slows digestion and helps reduce food intake by making you feel fuller for longer.

Many users report noticeable improvements in energy levels, weight control, and overall well-being. Tirzepatide 40mg is often prescribed after a period of dose escalation, meaning patients usually start on a lower dose before reaching the 40mg maintenance dose.

In addition to its benefits, like any medication, Tirzepatide can have side effects. The most common include nausea, mild digestive discomfort, or reduced appetite, especially when starting the treatment. These effects are usually temporary and tend to decrease as your body adjusts.

Tirzepatide is marketed under brand names such as Mounjaro and is available by prescription only. It's important to speak with your healthcare provider to determine whether this medication is right for your health goals. Whether you're managing diabetes, working toward weight loss, or both, Tirzepatide 40mg may offer the advanced support you've been looking for.

Our website provides detailed guidance on Tirzepatide availability, dosage information, and answers to common questions. We’re committed to helping you understand your options and access treatment safely and effectively.

Tirzepatide 60 peptide

Request Callback

₹ 10200 / Vial Get Latest Price

Product Brochure
Strength60mg
Packaging TypeInjection
Brandziska
Manufacturerziska
PrescriptionNo
Usage / Application2 type diabetes
Storage Conditionstemperature
made inIndia
shelf life36 month

Minimum order quantity: 5 Vial

Tirzepatide is a synthetic peptide drug designed to treat type 2 diabetes and support weight loss. It functions as a dual incretin receptor agonist, meaning it activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual action makes Tirzepatide unique compared to traditional GLP-1 agonists, offering enhanced effects on blood sugar control and appetite regulation.

As a peptide, Tirzepatide is composed of 39 amino acids and is administered via weekly subcutaneous injections, which helps improve patient adherence. One of its key benefits is its ability to significantly reduce body weight by suppressing appetite, slowing gastric emptying, and enhancing satiety. This makes it highly effective not only for type 2 diabetes management but also as a promising treatment for obesity.

Tirzepatide enhances insulin sensitivity and lowers HbA1c levels, a marker for long-term glucose control. Clinical trials, especially the SURPASS trials, have shown Tirzepatide to outperform other diabetes medications, including semaglutide. Its dual receptor action leads to greater glucose-dependent insulin secretion and better overall metabolic health.

It was approved by the FDA in 2022 under the brand name Mounjaro, developed by Eli Lilly. Tirzepatide is currently prescribed primarily for adults with type 2 diabetes, though research is ongoing into its broader applications, including cardiovascular risk reduction.

While highly effective, it does come with potential side effects, most commonly nausea, vomiting, diarrhea, and constipation, especially during the initial dose escalation phase. To minimize discomfort, dosing typically starts low and increases gradually. It's important to note that Tirzepatide is not approved for type 1 diabetes or as a substitute for insulin in insulin-dependent patients.

In summary, Tirzepatide 60 represents a major advancement in peptide-based metabolic therapy, combining potent glucose control with significant weight loss benefits through its dual action on GIP and GLP-1 receptors.

Tirzepatide 20mg peptide

Request Callback

₹ 6833.44 / Vial Get Latest Price

Product Brochure
Strength20mg
Packaging Size0.5 ml
Packaging TypeInjection
Brandziska
Manufacturerziska
PrescriptionNo
Usage / Application2 type diabetes
Storage Conditionsnormal temprature
made inindia
shelf life36 month

Minimum order quantity: 5 Vial

Tirzepatide 20mg – Effective Treatment for Blood Sugar Control and Weight Loss

Tirzepatide 20mg is a trusted injectable medication used to manage type 2 diabetes and support weight reduction. As a GIP and GLP-1 receptor agonist, it offers a unique dual-action mechanism that helps regulate blood glucose levels and reduce appetite more effectively than many other diabetes medications.

This mid-level dose of Tirzepatide is often prescribed after initial dose titration and is suitable for individuals who need stronger metabolic control. By enhancing insulin production when glucose is high and decreasing glucagon levels, Tirzepatide helps maintain stable blood sugar throughout the day. It also slows gastric emptying, which supports appetite suppression and can aid in gradual, healthy weight loss.

Tirzepatide 20mg is commonly used as part of a weekly injection routine. It can be a key step for patients progressing through their treatment journey or for those whose current regimen is not providing sufficient results. Many patients begin to notice improved energy levels, lower fasting blood sugar, and reduced food cravings within weeks of consistent use.

This medication is marketed under brands like Mounjaro and must be prescribed by a healthcare provider. It has become an increasingly popular option for those who are managing diabetes while also seeking weight management support. Tirzepatide is often used alongside a healthy lifestyle plan including diet and physical activity.

Mild side effects may occur, especially when starting treatment. These can include nausea, decreased appetite, or digestive discomfort. Most people tolerate the medication well as their body adjusts over time.

If you're looking for a powerful solution to control blood sugar and support your weight loss journey, Tirzepatide 20mg may be the right fit. It is one of the most advanced therapies available today, backed by clinical research and real-world results.

Visit our website to learn more about how Tirzepatide 20mg works, how to access treatment, and whether it’s a good option for your specific health needs. We provide up-to-date guidance, expert advice, and safe ordering support to help you on your path to better health.


Tirzepatide 10mg peptide

Request Callback

₹ 4270 / Vial Get Latest Price

Product Brochure
Strength10 mg
Packaging Size0.5 ml
Packaging TypeInjection
Brandziska
Manufacturerziska
PrescriptionNo
Usage / Application2 types diabetes
Storage Conditionsnormal temperature
made inIndia
shelf life36 month

Minimum order quantity: 5 Vial

irzepatide 10mg – Innovative Peptide Therapy for Diabetes and Weight Loss

Tirzepatide 10mg is a breakthrough peptide therapy used for controlling blood sugar and promoting weight loss. As a once-weekly injection, it combines the actions of GIP and GLP-1 hormones to improve insulin sensitivity, regulate appetite, and support long-term metabolic health. This 10mg dose is typically prescribed during the early phase of treatment, following initial dose escalation from lower levels.

This peptide works by mimicking natural gut hormones that influence how your body processes sugar and fat. By enhancing insulin production and reducing glucose output from the liver, Tirzepatide helps patients achieve better glycemic control. It also slows digestion and reduces hunger, which supports steady and sustainable weight loss.

Tirzepatide 10mg is ideal for people with type 2 diabetes or those following a medically supervised weight loss plan. It may also be suitable for patients who are not seeing results with other GLP-1 medications or who are beginning a new peptide therapy regimen. It is marketed under brand names like Mounjaro and is available by prescription only.

Many users find that this 10mg dose is well-tolerated, with fewer side effects than higher doses. Some mild symptoms may include nausea, decreased appetite, or slight gastrointestinal discomfort, especially in the early weeks. These typically improve as the body adjusts to the medication.

Tirzepatide has quickly become one of the most trusted peptide treatments for individuals looking to take control of their blood sugar and weight. It supports both short-term improvements and long-term health outcomes when combined with a healthy diet and lifestyle.

If you’re exploring peptide therapy options, Tirzepatide 10mg offers a powerful, science-backed solution. Whether you’re managing diabetes or working toward better weight control, this innovative treatment could be a key part of your journey.

Our website offers guidance on how to access Tirzepatide 10mg, understand dosing schedules, and connect with licensed providers. Learn more about how this peptide works and why it’s become a leading option in

X

Contact Us

Triaksh Warkar (CEO)
Triaksh Enterprises
Ground Floor, Plot No 87, C No 15/21, DR Ambedkar Road, Lashkari Bagh, Near Pachpawali Police Line
Nagpur - 440017, Maharashtra, India

Get Directions
Send Email
Share: